Haemonetics (HAE) Stock Up 10.9% YTD: Will the Rally Continue?

Its earnings are expected to grow 12% in the next five years. HAE's ROE for the trailing 12 months was 4.6%, better than the industry average of 0.2%. Will the Upside Continue? The Zacks Consensus Estimate for HAE's 2025 earnings is pegged at $1.40, indicating a 6.9% increase from the year-ago reported figure. The consensus estimate for 2025 revenues is pegged at $4.46 billion, indicating a year- over-year improvement of 12.6%. Haemonetics is gaining from the newly-completed limited market release of the ne ...